Insightful discussion on the latest research in PRRT and drug development at ENETS-NANETS webinar

ENETS shared a post on LinkedIn:

“A big thank you to all participants and our outstanding panellists from European Neuroendocrine Tumor Society (ENETS) and The North American Neuroendocrine Tumor Society (NANETS) for yesterday’s insightful discussion on the latest research in PRRT (Peptide Receptor Radionuclide Therapy) and drug development.

Our first collaborative ENETS-NANETS webinar was watched live by over 60 viewers from around the world. Missed it? The recording is now available in the ENETS webinar archive, and you can watch it for free here.

See you in two weeks’ time for part 3 of the ENETS-NANETS webinar when our experts will be discussing current trials and how these trials could provide new insights, directions, and signals in clinical NET practice.
For more details, follow this link.”

Source: ENETS/LinkedIn